This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

WCK 5222

Wockhardt Limited

Drug Names(s): WCK5222, WCK-5222, zidebactam and cefepime

Description: WCK 5222 (zidebactam and cefepime) is an antibiotic for gram negative infections. WCK 5222 is a new class of antibiotic being developed for complicated Urinary Tract Infections and Hospital Acquired Bacterial Pneumonia. In Q4 2015, the US FDA granted WCK 5222 Qualified Infectious Disease Product (QIDP) status.


WCK 5222 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug